Furthermore, Ch25h was found to be overexpressed in brains of AD patients as well as in mouse models of amyloid deposition and tau-mediated neurodegeneration (65) and 25-HC levels are increased in cerebrospinal fluid of late-stage AD patients, as well as in AD brains tissue and mitochondria (144). The gene discussed is MAPT; the disease is Alzheimer disease.